InvestorsHub Logo
Followers 1
Posts 613
Boards Moderated 0
Alias Born 07/28/2021

Re: GreeseMonkey post# 17355

Thursday, 05/18/2023 7:46:27 PM

Thursday, May 18, 2023 7:46:27 PM

Post# of 20436
"But Todos has millions in revenue (from last filings), years of SEC filings, clinical trials, real assets to be developed and brought to market, employees, a website with great detail on their products, testing, safety profile, etc., and partnerships with reputable companies. They have published studies and data in the biotech and medical communities. Sure, they're a small company with financial issues of many small companies, trying to grow into a larger company, pursuing multiple avenues to get there."

1) But if it were worth anything don't you think it would've been scoooped up by a big player?
I do.
2) Never got an EUA
3) Mobile testing flunked out.
4) Tollovir went nowhere after phase II
5) Influencers are useless
6) Flag football flopped
7) Stopped filing. Now pink limited
8) website still says 50 million in Botanical revenue in 2023. Yet I don't think 1 machine is up and running yet.
9) SP has gone from 10 cents to .0010 in 18 months
10 ) Dilution at 2.3 BILLION and climbing fast

Not looking good despite all the points you mention.

All in my opinion
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOMDF News